Table 1. Participant characteristics of the 39 participants that completed the study protocol. Data were obtained at baseline and values are expressed as mean (± SEM).
Total (n=39)
Citrus Flavonoid (CF) (n=19)
Placebo (n=20)
Age (yr)
23.0 (.3)
22.7 (.4)
23.6 (.4)
Weight (kg)
74.4 (1.29)
74.1 (1.75)
74.8 (1.93)
Height (m)
1.84 (.01)
1.83 (.02)
1.84 (.02)
BMI (kg·m-2)
22.1 (.30)
22.1 (.42)
22.0 (.44)
Exercise time per week
9.6 (.6)
8.8 (.6)
10.3 (.9)
Absolute power (W)
299.3 (7.7)
298.0 (10.8)
300.5 (11.4)
Relative power (W·kg-1)
4.0 (.1)
4.0 (.2)
4.0 (.2)
Heart rate (BPM)
174(2)
171(4)
177(3)
Average VO2 (mL·kg-1·min)
50.3 (1.3)
51.1 (1.6)
49.6 (2.1)
Estimated VO2max (mL·kg-1·min)
57.1 (1.2)
57.9 (1.6)
56.5 (1.8)
VO2/Power ratio
.172 (.003)
.176 (.005)
.170 (.004)
Peak power output (W)
332.5 (21.0)
359.4 (36.0)
306.8 (22.0)
No significant differences were found between CF and placebo group at baseline, p > 0.05.